journal article·2018-12

Smart vaccine delivery based on microneedle arrays decorated with ultra-pH-responsive copolymers for cancer immunotherapy

Huu Thuy Trang Duong, Yue Yin, Thavasyappan Thambi, Thanh Loc Nguyen, V.H. Giang Phan, Min Sang Lee, Jung Eun Lee, Jaeyun Kim, Ji Hoon Jeong, Doo Sung Lee

Biomaterials· Volume 185
Publisher page

Abstract

Despite the tremendous potential of DNA-based cancer vaccines, their efficacious delivery to antigen presenting cells to stimulate both humoral and cellular response remains a major challenge. Although electroporation-based transfection has improved performance, an optimal strategy for safe and pain-free vaccination technique remains elusive. Herein, we report a smart DNA vaccine delivery system in which nanoengineered DNA vaccine was laden on microneedles (MNs) assembled with layer-by-layer coating of ultra-pH-responsive OSM-(PEG-PAEU) and immunostimulatory adjuvant poly(I:C), a synthetic double stranded RNA. Transcutaneous application of MN patches onto the mice skin perforate the stratum corneum with minimal cell damage; subsequent disassembly at the immune-cell-rich epidermis/dermis allows the release of adjuvants and DNA vaccines, owing to the ultra-sharp pH-responsive nature of OSM-(PEG-PAEU). The released adjuvant and DNA vaccine can enhance dendritic cell maturation and induce type I interferons, and thereby produce antigen-specific antibody that can achieve the antibody-dependent cell-mediated cytotoxicity (ADCC) and CD8+ T cell to kill cancer cells. Strikingly, transcutaneous application of smart vaccine formulation in mice elicited 3-fold greater frequencies of Anti-OVA IgG1 serum antibody and 3-fold excess of cytotoxic CD8+ T cell than soluble DNA vaccine formulation. As a consequence, the formulation rejected the murine B16/OVA melanoma tumors in C57BL/6 mice through the synergistic activation of antigen-specific ADCC and cytotoxic CD8+ T cells. The maneuvered use of vaccine and adjuvant poly(I:C) in MNs induces humoral and cellular immunity, which provides a promising vaccine technology that shows improved efficacy, compliance, and safety.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Advancements in Transdermal Drug Delivery · Immunotherapy and Immune Responses · Dermatology and Skin Diseases

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (47)

Show source-provided references
1. Microenvironmental regulation of metastasis10.1038/nrc2618 ↗
2. Tailoring biomaterials for cancer immunotherapy: emerging trends and future outlook
3. Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy10.1038/nnano.2017.113 ↗
4. Engineering synthetic vaccines using cues from natural immunity10.1038/nmat3775 ↗
5. Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy10.1038/nbt.3071 ↗
6. An immunogenic personal neoantigen vaccine for patients with melanoma10.1038/nature22991 ↗
7. Particulate vaccines: on the quest for optimal delivery and immune response10.1016/j.drudis.2011.04.006 ↗
8. Reduction‐sensitive dextran nanogels aimed for intracellular delivery of antigens10.1002/adfm.201500894 ↗
9. A powerful CD8+ T-cell stimulating D-tetra-peptide hydrogel as a very promising vaccine adjuvant10.1002/adma.201601776 ↗
10. Immunological principles guiding the rational design of particles for vaccine delivery10.1021/acsnano.6b07343 ↗
11. Engineering N-glycosylation mutations in IL-12 enhances sustained cytotoxic T lymphocyte responses for DNA immunization10.1038/nbt0402-381 ↗
12. Enhancing immune responses using suicidal DNA vaccines10.1038/nbt0698-562 ↗
13. Single-round infectious particles enhance immunogenicity of a DNA vaccine against West Nile virus10.1038/nbt1400 ↗
14. Polyplex-releasing microneedles for enhanced cutaneous delivery of DNA vaccine10.1016/j.jconrel.2014.01.016 ↗
15. Nutlin‐3a and cytokine Co‐loaded spermine‐modified acetalated dextran nanoparticles for cancer chemo‐immunotherapy
16. Engineering nanoparticle-coated bacteria as oral DNA vaccines for cancer immunotherapy10.1021/acs.nanolett.5b00570 ↗
17. A peptide-based nanofibrous hydrogel as a promising DNA nanovector for optimizing the efficacy of HIV vaccine10.1021/nl404560v ↗
18. One‐shot immunomodulatory nanodiamond agents for cancer immunotherapy10.1002/adma.201506232 ↗
19. Nanoparticulate delivery of cancer cell membrane elicits multiantigenic antitumor immunity
20. Liposome-encapsulated antigens are processed in lysosomes, recycled, and presented to T cells10.1016/0092-8674(91)90647-H ↗
21. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns10.1038/nri2868 ↗
22. Dendritic cell-based cancer therapeutic vaccines10.1016/j.immuni.2013.07.004 ↗
23. Synthetic nanoparticles for vaccines and immunotherapy10.1021/acs.chemrev.5b00109 ↗
24. Multistaged nanovaccines based on porous Silicon@Acetalated Dextran@Cancer cell membrane for cancer immunotherapy
25. A protective vaccine delivery system for in vivo T cell stimulation using nanoengineered polymer hydrogel capsules10.1021/nn900715g ↗
26. Lipid nanoparticle assisted mRNA delivery for potent cancer immunotherapy10.1021/acs.nanolett.6b03329 ↗
27. Injectable cryogel-based whole-cell cancer vaccines10.1038/ncomms8556 ↗
28. Composite dissolving microneedles for coordinated control of antigen and adjuvant delivery kinetics in transcutaneous vaccination10.1002/adfm.201201512 ↗
29. Releasable layer-by-layer assembly of stabilized lipid nanocapsules on microneedles for enhanced transcutaneous vaccine delivery10.1021/nn302639r ↗
30. Nano-layered microneedles for transcutaneous delivery of polymer nanoparticles and plasmid DNA10.1002/adma.201001525 ↗
31. Structure-based programming of lymph-node targeting in molecular vaccines10.1038/nature12978 ↗
32. Microneedles for drug and vaccine delivery10.1016/j.addr.2012.04.005 ↗
33. Effective humoral immune response from a H1N1 DNA vaccine delivered to the skin by microneedles coated with PLGA-based cationic nanoparticles10.1016/j.jconrel.2017.04.027 ↗
34. Enhanced cancer immunotherapy by microneedle patch-assisted delivery of anti-PD1 antibody10.1021/acs.nanolett.5b05030 ↗
35. Hypoxia and H2O2 dual-sensitive vesicles for enhanced glucose-responsive insulin delivery10.1021/acs.nanolett.6b03848 ↗
36. Polymer multilayer tattooing for enhanced DNA vaccination10.1038/nmat3550 ↗
37. Skin dendritic cell targeting via microneedle arrays laden with antigen-encapsulated poly-d,l-lactide-co-glycolide nanoparticles induces efficient antitumor and antiviral immune responses10.1021/nn304235j ↗
38. Toll-like receptor 3 promotes cross-priming to virus-infected cells10.1038/nature03326 ↗
39. Assembly and immunological processing of polyelectrolyte multilayers composed of antigens and adjuvants10.1021/acsami.6b06275 ↗
40. Immunity by formulation design: induction of high CD8+ T-cell responses by poly(I:C) incorporated into the CAF01 adjuvant via a double emulsion method10.1016/j.jconrel.2010.11.021 ↗
41. Microneedle arrays coated with charge reversal pH-sensitive copolymers improve antigen presenting cells-homing DNA vaccine delivery and immune responses10.1016/j.jconrel.2017.11.025 ↗
42. Mussel-inspired polydopamine: a biocompatible and ultrastable coating for nanoparticles in vivo10.1021/nn404117j ↗
43. Injectable hydrogels for sustained release of therapeutic agents10.1016/j.jconrel.2017.08.006 ↗
44. Enhancing neurogenesis and angiogenesis with target delivery of stromal cell derived factor-1α using a dual ionic pH-sensitive copolymer10.1016/j.biomaterials.2015.05.025 ↗
45. Endosomal size and membrane leakiness influence proton sponge-based rupture of endosomal vesicles10.1021/acsnano.7b07583 ↗
46. Analgesic microneedle patch for neuropathic pain therapy10.1021/acsnano.6b06104 ↗
47. Molecularly engineered poly(ortho ester) microspheres for enhanced delivery of DNA vaccines10.1038/nmat1075 ↗